Login / Signup

Identification of poor prognostic joint locations in an early rheumatoid arthritis cohort at risk of rapidly progressing disease: a post-hoc analysis of the Phase III AGREE study.

Patrick DurezRene WesthovensFemke BaekeYedid ElbezSofie RobertHarris A Ahmad
Published in: BMC rheumatology (2022)
ClinicalTrials.gov NCT00122382, registered July 2005.
Keyphrases
  • phase iii
  • rheumatoid arthritis
  • open label
  • clinical trial
  • double blind
  • phase ii
  • disease activity
  • randomized controlled trial
  • interstitial lung disease
  • study protocol
  • systemic sclerosis
  • bioinformatics analysis